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Abstract
Epizootic haemorrhagic disease virus (EHDV) infects wild ruminants, causing a frequently fatal haemorrhagic disease.
However, it can also cause bluetongue-like disease in cattle, involving significant levels of morbidity and mortality,
highlighting a need for more rapid and reliable diagnostic assays. EHDV outer-capsid protein VP2 (encoded by genome-
segment 2 [Seg-2]) is highly variable and represents the primary target for neutralising antibodies generated by the
mammalian host. Consequently VP2 is also the primary determinant of virus ‘‘serotype’’, as identified in virus neutralisation
tests (VNT). Although previous reports have indicated eight to ten EHDV serotypes, recent serological comparisons and
molecular analyses of Seg-2 indicate only seven EHDV ‘‘types’’. Oligonucleotide primers were developed targeting Seg-2, for
use in conventional RT-PCR assays to detect and identify these seven types. These assays, which are more rapid and
sensitive, still show complete agreement with VNT and were used to identify recent EHDV isolates from the Mediterranean
region and North America.
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Introduction
Epizootic haemorrhagic disease virus (EHDV) is a distinct virus
species within the genus Orbivirus, family Reoviridae, that is closely
related to the ‘type species’ Bluetongue virus (BTV) [1,2]. The
EHDV particle has typical orbivirus morphology, consisting of an
icosahedral virus-core (approximately 80 nm in diameter) com-
posed of three concentric protein layers [1–4]. The inner ‘subcore’
layer, is composed of 120 copies of structural protein VP3 and
surrounds three minor protein components, VPl, VP4 and VP6, as
well as the ten linear dsRNA segments of the virus genome (Seg-1
to Seg-10) [5,6]. The outer-core layer is composed of 780 copies of
VP7 and provides a surface for attachment of the 60 trimers of
VP2 and 180 trimers of VP5, which form the outer capsid layer
[7–11]. Three different non-structural proteins, NS1, NS2, and
NS3/NS3a, have also been identified in EHDV infected cells
[1,12,13].
The current report by the International Committee for the
Taxonomy of Viruses (ICTV) [2] indicates that there are eight
serotypes of EHDV [2], which can be identified by the specificity
of neutralising antibody interactions with the outer-surface of the
virus (particularly with VP2) in ‘virus neutralisation tests’ (VNT)
[14–16]. VP2 is the most variable of the EHDV proteins, showing
sequence differences that correlate with both the serotype and
geographic origin (topotype) of the virus lineage [2,15,17].
However, recent molecular and serological data presented by
Anthony et al [15] showed that the EHDV isolate from Nigeria
(NIG1967/01) that is used at Institute for Animal Health (IAH) as
a reference strain for EHDV-3, cross-neutralises in VNTs with the
reference isolate of EHDV-1 (New Jersey - USA1955/01),
indicating that they in fact belong to the same ‘serotype’. EHDV
strain ‘318’, which was first isolated in Bahrain in 1983
(BAR1983/01) and subsequently recovered from sentinel calves
in the Sudan [15,18,19] was (for both isolates) identified as a
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12782western strain of EHDV-6 (EHDV-6[W]). Consequently only
seven distinct types of EHDV were identified [15].
Both EHDV-1 and EHDV-2 have been responsible for
numerous large-scale epizootics in wild ungulates (especially
white-tailed deer), sometimes with significant fatalities [20].
EHDV-1 (New Jersey strain- USA1955/01) was first described
in the north-eastern USA [21]. EHDV-2 (represented by the
Alberta strain - CAN1962/01), was originally isolated in southern
Alberta, Canada, in 1962 [22] but is also known to circulate in
both Australia and Japan (Ibaraki virus - JAP1959/01) [23,24].
EHDV serotypes 3 and 4 had only ever been reported in Africa
[25] (although there is now evidence that EHDV-3 is the same
type as EHDV-1 – [15]). EHDV serotypes 5, 6 (represented by the
prototype strain CSIRO 753), 7 and 8 were originally identified in
Australia [16,23]. Initially only EHDV-1 and 2 were identified on
more than one continent. However, EHDV-6 has recently been
identified in both the Middle East (strain 318) and the USA [17],
and EHDV-7 was identified in Israel during 2006, showing that
other EHDV serotypes also exist in widely separated geographic
locations.
Under field conditions, EHDV can infect several different
ruminant species, although clinical signs occur most often in wild
ungulates (including white-tailed deer, mule deer and antelope). In
these species the infection can be very debilitating and is often fatal
[22,26,27]. Although EHDV infection is generally inapparent or
very mild in livestock species [28], more severe ‘bluetongue-like’
disease was observed in cattle in Japan during 1959 [17,29–32]
and more recently in Israel, Morocco and Turkey during (2006–
2007) [33–35].
Since 1998, multiple different BTV types have caused
widespread disease outbreaks in Europe [36–40]. These events,
which demonstrate the presence of vector-competent Culicoides
species across the entire region, have been linked to climate
change [41]. During the same period, multiple, previously exotic
BTV types, were also isolated in the southern states of the USA
[42]. The primary involvement of EHDV with wild rather than
domesticated species, and a lack of rapid/reliable molecular
assays, has lead to lack of information concerning the prevalence
and distribution of different EHDV types, particularly in the
Middle East and the Indian sub-continent. However, it is clear
that EHDV has recently also expanded its geographic distribution
and economic importance, with outbreaks in livestock in Israel,
Morocco, Algeria, Turkey, the USA and Reunion Island during
2004–2009 [34,35,43–54]. These events suggest that EHD
represents an increasing threat to southern Europe and the
USA, and are reflected by its declaration as a notifiable disease by
OIE [55].
Conventional procedures for the detection and typing of EHDV
involve virus isolation in embryonated chicken eggs (ECE) or
sheep, and/or adaptation to cell culture, followed by ‘typing’ using
reference antiserum against the established serotypes in ‘virus
neutralisation tests’ (VNT) [56]. Alternatively antiserum from
infected animals can also be tested for its ability to neutralise
reference strains of each virus serotype in ‘serum neutralisation
tests’ (SNT) [57]. However, these procedures are costly, time
consuming and require access to reference viruses and/or antisera.
Experience with BTV suggests that they are also prone to cross-
reactions between types, particularly in areas where multiple virus
serotypes are co-circulating [58,59]. RT-PCR based molecular
assays have recently been developed for individual BTV types [60–
63] that are more rapid and more reliable than these conventional
serological methods and have become standard diagnostic tests in
many BTV reference laboratories. However, to improve EHDV
surveillance, there is a need for similar molecular assays to identify
and ‘type’ EHDV infections.
Detection of EHDV has previously been reported using either
real time or conventional RT-PCR assays, containing virus-
species/serogroup specific primers and probes targeting conserved
genome segments 5, 7 and/or 10 (NS1, VP7 and/or NS3 genes
respectively) [14,64–68]. This report describes the development of
a new panel of EHDV ‘type-specific’ primers targeting genome
segment 2 (Seg-2 - the VP2 gene), and their use to type and
characterise EHDV strains involved in recent disease outbreaks in
the Mediterranean region and North America.
Materials and Methods
Field isolates
The different EHDV and other orbivirus isolates (listed in
Table 1 and 2) were grown in BHK-21 cell monolayers, until
100% cytopathic effect (CPE) was observed. Each isolate is stored
in the IAH ‘dsRNA virus reference collection’ (dsRNA-VRC) with
a collection number composed of ‘country code, year, and the
number of the isolate in that year from that country [48,49]. The
samples used in these studies were taken from naturally infected
animals in the field, by qualified veterinarians, as part of normal
veterinary care and diagnostic testing procedures in the respective
countries.
Moroccan and Algerian EHDV isolates 2006. During
2006 an outbreak of EHD occurred in cattle near Ahfir in the
East of Morocco. The virus was isolated in embryonated chicken
eggs (ECE) at Biopharma Laboratory in Rabbat, Morocco,
followed by passage in BSR cells, a clone of BHK-21 cells
(designated isolate 2-451- passage 1E3BSR). A sample of the virus
was sent to IAH Pirbright, passaged twice in BHK-21 cells, and
then stored as isolate MOR2006/05. EHDV ALG2006/02 was
isolated in BHK-21 cells (at IAH), from a lymph sample taken
from a cow showing clinical signs of disease, during August 2006 in
Medea, Algeria.
Israeli EHDV isolates 2006. Ten isolates were made in
ECE at the Kimron Institute in Israel, from the blood of cows
showing clinical signs of disease in the Jordan Valley. These
isolates, which were provisionally identified as EHDV, were sent
to IAH Pirbright and passaged once in BHK-21 cells, then stored
in the dsRNA-VRC as isolates ISR2006/01 to ISR2006/09 and
ISR2006/13.
American EHDV isolates 2006. In September, 2006,
viruses were isolated by inoculation of cattle pulmonary artery
endothelial (CPAE) cells cultures from tissues of a captive white-
tailed deer from Iroquois County, Illinois, (Sample 06-473906-1
[dsRNA-VRC number USA2006/05]) and a wild deer from
Vermillion County, Indiana (Sample 06-473906-2 [USA2006/06/])
[51,52]. Four additional isolates from captive deer including one
from Henry County, Indiana (Sample 06-473906-3 [dsRNA-VRC
number USA2006/07]), and two from Iroquois County, Illinois (06-
473906-5 - USA2006/08 and 06-473906-6 - USA2006/09) were
confirmed as EHDV at the Southeastern Cooperative Wildlife
Disease Study (SCWDS). Although these isolates tested positive for
EHDV by RT-PCR, virus neutralisation techniques failed to detect
either EHDV-1 or EHDV-2 (the types previously identified in the
USA) at the SCWDS. The virus isolates were subsequently sent to
the USDA National Veterinary Services Laboratories (NVSL) for
additional VNT testing. The isolates were then sent to IAH,
Pirbright, for serotype identification and confirmation, where they
were grown in BHK-21 cells and stored in the dsRNA-VRC as
mentioned above.
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collectedfromsixcowsthatwerethought to be infected withEHDV,
in the Mugla region of Turkey, during June/July of 2007. These
were used to inoculate KC cells (Culicoides sonorensis cell line) at IAH
Pirbright, generating virus isolates TUR2007/01 to TUR2007/06.
A sample of bovine organ homogenate (lung and spleen),
t a k e no n2 6
th June 2007 from the Fethiye-Mugla region of
Turkey, was also sent to IAH Pirbright and used to infect KC
cells, generating isolate TUR2007/07. This was identified as
EHDV using a serogroup specific real time RT-PCR targeting
Table 1. List of EHDV isolates used in this study.
IAH-P* dsRNA virus reference collection
number
Accession numbers for genome
Seg-2 EHDV Serotype** (strain) Location (year)
Reference strains of EHDV (Eastern [E]/Western [W])
AUS1995/02[E] HM156728 1(DPP2209 (95/724 #12)) Australia (1995)
USA1955/01[W] AM744978 1 (New Jersey) USA (1955)
NIG1967/01 AM745008 1 (Ib Ar 22619) Nigeria (1967)
JAP1959/01[E] AM745078 2 (Ibaraki virus) Japan (1959)
AUS1979/05 AM744988 2 (CSIRO 439) Australia (1979)
CAN1962/01[W] AM744998 2 (Alberta) Canada (1962)
JAP----/08 – 2 (Ibaraki virus) Japan
NIG1968/01[W] AM745018 4 (Ib Ar 33853) Nigeria (1968)
AUS1977/01[E] AM745028 5 (CSIRO 157) Australia (1977)
AUS1981/07[E] AM745038 6 (CSIRO 753) Australia (1981)
BAR1983/01[W] AM745068 6 (strain 318) Bahrain (1983)
AUS1981/06[E] AM745048 7 (CSIRO 775) Australia (1981)
ISR2006/13[W] HM156731 6 [W] & 7[W]*** Israel, Jordan Valley (2006)
AUS1982/06[E] AM745058 8 (DPP59) Australia (1982)
Other field strains of EHDV
ALG2006/02 HM156729 6[W] Medea, Algeria (2006)
MOR2006/05 HM156730 6[W] Ahfir, Morocco (2006)
ISR2006/01 – 7[W] Israel, Jordan Valley (2006)
ISR2006/02 – 7[W] Israel, Jordan Valley (2006)
ISR2006/03 – 7[W] Israel, Jordan Valley (2006)
ISR2006/04 – 7[W] Israel, Jordan Valley (2006)
ISR2006/05 – 7[W] Israel, Jordan Valley (2006)
ISR2006/06 – 7[W] Israel, Jordan Valley (2006)
ISR2006/07 – 7[W] Israel, Jordan Valley (2006)
ISR2006/08 – 7[W] Israel, Jordan Valley (2006)
ISR2006/09 – 7[W] Israel, Jordan Valley (2006)
USA2006/05 – 6[E] Iroquois County IL, USA (2006)
USA2006/06 – 6[E] Vermillion County IN, USA (2006)
USA2006/07 – 6[E] Henry County IN, USA (2006)
USA2006/08 – 6[E] Iroquois County IL, USA (2006)
USA2006/09 – 6[E] Iroquois County IL, USA (2006)
TUR2007/01 – 6[W] Mugla Turkey (2007)
TUR2007/02 – 6[W] Mugla Turkey (2007)
TUR2007/03 – 6[W] Mugla Turkey (2007)
TUR2007/04 – 6[W] Mugla Turkey (2007)
TUR2007/05 – 6[W] Mugla Turkey (2007)
TUR2007/06 – 6[W] Mugla Turkey (2007)
TUR2007/07 – 6[W] Fethiye- Mugla Turkey (2007)
Full details of these isolates are presented in [15], and are also available on the dsRNA virus reference collection website [48].
*Institute for Animal Health, Pirbright.
**Serotypes listed are as reclassified by Anthony et al [15], with NIG1967/01 as serotype 1, not serotype 3. They have also characterised the unclassified strain ‘318’ as a
western topotype of serotype 6 (EHDV-6[W]).
***The only available sequence for a western strain of EHDV-7 was derived from a mixed virus isolate.
doi:10.1371/journal.pone.0012782.t001
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International - LSI).
Extraction of Viral dsRNA
The dsRNA extracted either from EHDV infected cell pellets
using the TrizolH (Invitrogen) [69], or from cell-free supernatant
fluid, using the QIAamp Viral RNA Mini Kit from Qiagen
according to manufacturer’s instructions. Each isolate was
processed separately to minimize the risk of sample-to-sample
contamination.
Selection of serotype-specific oligonucleotide primers
Comparisons of full-length VP2 sequences already obtained for
strains of the different EHDV serotypes [14,15] (listed in Table 1), as
well as those generated during these studies (EHDV-1/AUS1995/02
[Ac. No. HM156728]; EHDV-6/ALG2006/02 [Ac. No, HM156729];
EHDV-6/MOR2006/05 [Ac. No.HM156730]; EHDV-7/ISR2006/
13 [Ac. No. HM156731]) facilitated the identification of unique regions
(showing intra-typic conservation and hetero-typic variation) in the Seg-
2, for the design of serotype-specific RT-PCR primers. Wherever
possible, these analyses included data for multiple isolates of each type,
from different geographical origins, to help ensure that the resulting
primers would amplify Seg-2 from different topotypes within the same
serotype.
At least two primer-pairs were designed for each serotype
(Table S1 – provided as online supporting information file).
Primer-pairs (identified by the letter ‘A’, indicating ‘all’) were
designed to detect any isolate of each EHDV serotype. Other
primers were designed targeting Seg-2 of either eastern or
western topotypes of each type (identified by the letters ‘E’ and
‘W’, respectively; Table S1 – supporting information). Individual
primers were named as follows: ‘EHDV’ representing Epizootic
haemorrhagic disease virus, followed by a number indicating the
serotype; ‘S2’ to indicate they target Seg-2; ‘F’ representing
forward, or ‘R’ representing reverse primers; and a number
corresponding to the nucleotide binding position of the primer in
Seg-2.
Reverse transcription and amplification of Seg-2
Complementary DNA (cDNA) copies were synthesised (reverse
transcribed) from denatured dsRNA templates, then amplified by
a ‘single-tube’ method, using the One-Step RT-PCR kit (Qiagen,
Courtaboeuf, France), using conditions described for amplification
of cDNAs from Seg-2 of bluetongue virus (BTV) by Mertens et al
[63]. Alternatively a single-tube reaction contained the Super-
Script
TM III one-step RT-PCR system (Invitrogen) and high
fidelity platinumH Taq was used with RNA templates extracted
from blood or cell culture supernatant, as described by Maan et al
[37]. In some cases, full length cDNA copies of EHDV Seg-2 were
also synthesised and sequenced, as described by Maan et al [70].
Sequencing of Seg-2 amplicons
For confirmation of RT-PCR typing results, amplified cDNA
products from Seg-2 were gel-purified and sequenced directly on
an Applied Biosystems BigDye ddNTP 3730 capillary sequencer,
using the PCR primers, as sequencing primers. The resultant
sequences were analysed and aligned using the Clustal W program
[71] and MAFFT (www.ebi.ac.uk/Tools/mafft/) and then
subjected to either BLAST analysis and/or in silico comparisons
to Seg-2 sequence data available for the 7 EHDV serotypes
(including both western and eastern strains). Phylogenetic
comparisons were made using Neighbour-Joining (NJ) algorithms
and the trees were constructed in MEGA ver. 4.1 software [72],
using nucleotide sequences in a pair-wise deletion, p-distance
algorithm, and bootstrapped using 500 replicates.
Results
Development of RT-PCR assays and their evaluation for
type specificity
Multiple primer-pairs were designed based on sequence data for
Seg-2, targeting each of the seven EHDV serotypes (Table 1 and
Table S1 - supporting information). These primers were tested in
RT-PCR reactions containing RNA extracted from BHK-21 cells
infected with the different EHDV serotypes (including both
eastern and western topotypes, where available - Table 1). The
resulting cDNAs were analysed by 1% agarose gel electrophoresis
(AGE), to check both their sizes and relative level of synthesis. In
each case, cDNAs of the expected size were generated from RNA
belonging to the homologous EHDV serotype (Fig. 1 and 2).
However, in most cases, significant amounts of cDNA of the
expected size were only amplified in reactions containing RNA of
Table 2. List of other orbiviruses used in this study.
Virus Strain IAH-P* dsRNA virus reference collection number
Bluetongue virus (BTV) 1–24 Reference strains from South Africa RSArrrr/01 – RSArrrr/24
African horse sickness virus (AHSV) 1–9 Reference strains from South Africa RSArrah/01 - RSArrah/08 and PAKrrah/09
Equine encephalosis virus (EEV) 1–6 Reference strains from South Africa RSA1976/01; RSA1967/01; RSA1971/04; RSA1974/04;
RSA1974/01; RSA1991/01
Andasibe virus – MAD1979/01
Chobar Gorge virus Chobar Gorge NEP1970/01
Japanaut virus – –
Eubenangee virus (EUBV) – AUS1978/03
Matucare virus – –
Tembe virus – BRA1963/01
Tracambe virus – BRA1985/01
Palyam virus (PALV) Sudan (SU3843) SUD1982/03
Full details of these isolates are available on the dsRNA website [49].
*Institute for Animal Health, Pirbright.
doi:10.1371/journal.pone.0012782.t002
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cDNAs from RNA of even the most closely related of the
heterologous EHDV serotypes, or from the other related
orbiviruses tested (Table 1 and 2) (data not shown). In some
serotypes it was possible to design primers using the combined
sequences from both eastern and western strains within an
individual serotype, which successfully amplified Seg-2 sequences
from both major topotypes. These initial evaluations confirm in
silico analyses, indicating that within the range of EHDV strains
tested (Table 1 and 2) the primers listed in Table S1 (supporting
information) are ‘type-specific’.
EHDV-1 (and 3). Three primer-pairs (‘1W1’, ‘1W2’ and
‘1W3’) were designed, based on sequence data for Seg-2 of two
western strains of EHDV-1 (USA1955/01 [Ac. No. AM744978]
and NIG1967/01 [Ac. No. AM745008]). NIG1967/01 was
previously classified as EHDV-3 but is now included in EHDV-1
[15]. Eastern topotype specific primer-pairs (‘1E1’ and ‘1E2’) were
also designed and evaluated, using Seg-2 sequence data generated
for EHDV-1/AUS1995/02 (Ac. No. HM156728). By combining
Seg-2 sequence data from both eastern and western strains, two
primer-pairs (‘1A1’ and ‘1A2’) were designed for amplification of
cDNAs from Seg-2 of any of the three EHDV-1 isolates.
Primer-pairs ‘1E1’ and ‘1E2’ successfully amplified Seg-2 from
the eastern strain of EHDV-1/AUS1995/02. Seg-2 of both
eastern and western strains of EHDV-1 could be amplified using
primer-pair ‘1A1’, while primer-pair ‘1A2’ amplified all strains of
EHDV-1 with the exception of NIG1967/01 (regardless of
topotype). None of the four pairs (‘1E1’, ‘1E2’, ‘1A1’ and 1A2’)
showed cross-amplification with Seg-2 from reference strains of the
remaining six EHDV serotypes, as shown for EHDV-6[W]/
BAR1983/01 (Fig. 1 – Panel A). Both of the eastern strain-specific
primer-pairs did not cross amplify when tested with the western
strains of EHDV-1.
Although all three western strain-specific primer-pairs amplified
cDNAs from several western isolates of EHDV-1 (including
USA2001/01, USA2001/02, USA2001/03) the level of cDNA
synthesis observed was significantly lower using primer-pair ‘1W1’
and RNA from NIG1967/01. No cross-amplification was detected
using ‘1W1’, 1W2’ and ‘1W3’ with RNA from an eastern strain of
EHDV-1/AUS1995/02 and other EHDV serotypes, as illustrated
in Fig. 1 - Panel B for Seg-2 from BAR1983/01 (a western strain of
EHDV-6).
EHDV-2. Two primer-pairs (‘2A1’ and ‘2A2’), were
designed, based on sequence data for Seg-2 of two eastern
strains (AUS1979/05 [Ac. No. AM744988] and JAP1959/01
[Ac. No. AM745078]) and one western strain (CAN1962/01
[Ac. No. AM744998]) of EHDV-2. These primers successfully
amplified cDNAs from Seg-2 of all three EHDV-2 isolates,
confirming their specificity for both eastern and western
t o p o t y p e so fE H D V - 2( F i g .1–P a n e lC ) .T h e ya l s of a i l e dt o
cross-react with any of the other EHDV serotypes, as illustrated
for isolate AUS1981/06 of EHDV-7 (the closest heterologous
serotype to EHDV-2), confirming ‘type’-specificity (Fig. 1 -
Panel C).
Figure 1. ‘Type-specific’ primers for Seg-2 of EHDV-1 and EHDV-2. The cDNAs amplified from Seg-2 of EHDV-1 or EHDV-2 using type-specific
primers, were analyzed by 1% agarose-gel-electrophoresis (AGE). Panel A: Lanes 1, 3, 5 and 9 show products from EHDV-1/AUS1995/02 using
primer-pairs ‘1E1’ (918 bp), ‘1E2’ (660 bp), ‘1A1’ (1199 bp) and ‘1A2’ (1500 bp) respectively. Lanes 6 and 10: EHDV-1/USA1955/01, using primer-pairs
‘1A1’ and ‘1A2’. Lanes 7 and 11: EHDV-1/NIG1967/01, using primer-pairs ‘1A1’ and ‘1A2’. Lanes 2, 4, 8 and 12: Primer-pairs ‘1E1’, ‘1E2’, ‘1A1’ and ‘1A2’
amplified only small amounts of ‘incorrectly’ sized products from EHDV-6/BAR1983/01 (heterologous-control). Lane +C: BTV-6/RSArrrr/06 with primer-
pair BTV-6/2/301F & BTV-6/2/790R (1631 bp) (+ve control: Maan et al [37]). Panel B: Lanes 1, 4 and 7 and Lanes 2, 5 and 8: Amplicons from EHDV-1/
USA1955/01 and EHDV-1/ NIG1967/01 (respectively), using primer-pairs ‘1W1’ (888 bp), ‘1W2’ (488 bp) and ‘1W3’(735 bp). Lanes 3, 6 and 9: Primer-
pairs ‘1W1’, ‘1W2’ and ‘1W3’ (respectively) generated only small amounts of ‘incorrectly’ sized products from EHDV-6/BAR1983/01 (heterologous-
control). Panel C: Primer-pairs ‘2A1’ (531 bp) and ‘2A2’ (612 bp) were used with EHDV-2/CAN1962/01(Lanes 1 and 4); EHDV-2/JAP1959/01 (Lanes 2
and 5); EHDV-2/AUS1979/05 (Lanes 3 and 6); and EHDV-7/AUS1981/06 (heterologous control - Lanes 7 and 8). No amplification was detected in the
control reactions. Panel D: Lanes 3 and 4 show amplicons from EHDV-2/CAN1962/01 and EHDV-2/USA1996/03 (respectively - both western strains)
using primer-pair ‘2W1’ (1942 bp). Lanes 1 and 2: amplicons from eastern-strains of EHDV-2 (JAP1959/01 and AUS1979/05). Lanes 5 to 11: EHDV-1/
USA1955/01, EHDV-4/NIG1968/01, EHDV-5/AUS1977/01, EHDV-6/USA2006/05, EHDV-7/AUS1981/06, EHDV-7/ISR2006/13 and EHDV-8/AUS1982/06
(respectively - as heterologous controls). Although minor bands were generated from both eastern-strains and heterologous-controls they were
‘incorrect’ sizes. Lane +C: products from BTV-6/NET2008/04, using primer-pair BTV-6/2/301F & BTV-6/2/790R (1631 bp) (+ve control: Maan et al [37]).
Lane –C: is a negative-control (water). For primer positions and sequences see Table S1.
doi:10.1371/journal.pone.0012782.g001
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[W] strain of EHDV-2, were also used to design two sets of
topotype specific primers, (‘2E1’ and 2W1’). The ‘2E1’ primer set
successfully amplified Seg-2 from two EHDV-2[E] strains
(AUS1979/05 and JAP1959/01) (data not show). Primer set
‘2W1’ also efficiently amplified cDNAs from two EHDV-2[W]
strains (CAN1962/01 and USA1996/03; Fig. 1 – Panel D). Both
‘2E1’ and ‘2W1’ primer sets generated multiple cDNA bands from
RNAs of heterologous EHDV serotypes (including isolate
AUS1981/06 [EHDV-7] – Fig. 1 – Panel D for ‘2W1’), and
from the heterologous topotype of EHDV-2, although none of
these was the correct size. This confirms both the serotype and
topotype specificity of primer sets ‘2E1’ and ‘2W1’ for EHDV-2.
EHDV-4 and EHDV-5. Two primers-pairs (‘4W1’ and
‘4W2’) were designed based on Seg-2 sequences from the
western strain of EHDV-4 (NIG1968/01 [Ac. No. AM745018]),
and two pairs (‘5E1’ and ‘5E2’) were based on an eastern strain of
EHDV-5 (AUS1977/01 [Ac. No. AM745028]). Each primer set
efficiently amplified cDNAs of the homologous virus strain and
even though serotypes 4 and 5 are the most closely related
serotypes to each other, no cross-reaction was detected between
them (Fig. 2 - Panel A1 and A2 and Fig. 3). Evaluation of each
primer-pair with the other heterologous EHDV serotypes (type 1,
2, 6, 7 and 8 – as listed in Table 1) also failed to amplify Seg-2,
confirming ‘type specificity’ (data not shown).
EHDV-6. sequence data for Seg-2 of an eastern and a western
isolate of EHDV-6, (AUS1981/07 [Ac. No. AM745038] and
BAR1983/01 [Ac. No. AM745068], respectively) were used to
design three sets of primers, one specific for the eastern topotype
(‘6E1’) and two for the western topotype (‘6W1’ and ‘6W2’).
Primer-pairs ‘6A1’ and ‘6A2’, were also designed from sequence
data for an eastern strain of EHDV-6 (AUS1981/07 [Ac. No.
AM745038]), amplified cDNAs from Seg-2 of both eastern and
western EHDV-6 isolates, including the eastern reference strain of
EHDV-6/AUS1981/07 as well as the eastern topotype of EHDV-
6 from the USA (USA2006/05 – USA2006/09). Both primer-
pairs (‘6A1’ and ‘6A2’) also generated cDNA bands of the correct
size from BAR1983/01, belonging to the western topotype of
EHDV-6 (Fig. 2 - Panel B).
In contrast primer-pairs ‘6E1’ as well as ‘6W1’ and ‘6W2’ only
amplified Seg-2 from AUS1981/07 (EHDV-6[E]) or BAR1983/
01 (EHDV-6[W]) respectively (Fig. 2 - Panel B – for ‘6W1’ and
‘6W2’). None of these EHDV-6 primer-pairs amplified cDNAs
from Seg-2 belonging to any of the other EHDV serotypes (data
not shown) including EHDV-8/AUS1982/06, the heterologous
serotype that is most closely related to BTV-6 (Fig. 2 - Panel B).
EHDV-7. Sequence data for Seg-2 from an eastern and a
western strain of EHDV-7 (AUS1981/06 [Ac. No. AM745048]
and ISR2006/13 [Ac. No. HM156731] respectively) were used to
design two primer-pairs for each topotype. Each primer-pair
amplified cDNAs from Seg-2 of the homologous strain of EHDV-
7 but no cross-topotype reaction was detected. No cross-
amplification was detected using RNA templates from other
EHDV reference strains belonging to serotype 1, 2, 4, 5, 6 and 8,
Figure 2. ‘Type-specific’ primers for Seg-2 of EHDV-4, 5, 6, 7 and 8. cDNAs amplified from Seg-2 of EHDV-4 to 8 using type-specific primers,
were analyzed by 1% agarose-gel-electrophoresis (AGE). Panel A1: Lanes 1 and 2: amplicons from EHDV-4/NIG1968/01, using primer-pairs ‘4W1’
(1161 bp) and ‘4W2’ (428 bp). Lanes 3 and 4: no products were generated from EHDV-5/AUS1977/01 (heterologous-control) using these primers.
Panel A2: Lane 7 and 8: products from EHDV-5/AUS1977/01 using primer-pairs ‘5E1’ (680 bp) and ‘5E2’ (2199 bp). Lanes 9 and 10: no products were
generated from EHDV-4/NIG1968/01 (heterologous-control) using these primer-pairs. Lane +C: products from BTV-1/RSArrrr/01, using primer-pair
BTV-1/2/p524F & BTV-1/2/p968R (1334 bp) (+ve control: Mertens et al [63]). Panel B: Amplicons from EHDV-6 /AUS1981/07 (Lanes 1 and 2) and
EHDV-6/BAR1983/01 (Lanes 3 and 4) using primer-pair ‘6A1’ (664 bp) and ‘6A2’ (859 bp). Lanes 5 and 6: smaller amounts of ‘incorrectly’ sized
products from EHDV-8/AUS1982/06 (heterologous control) using the same primers. Lanes 7 and 8: amplicons from EHDV-6/BAR1983/01 using primer-
pairs ‘6W1’ (573 bp) and ‘6W2’ (468 bp). Neither primer-pair amplified Seg-2 from EHDV-6/AUS1981/07 (eastern isolate - lanes 9 and 11), or EHDV-8/
AUS1982/06 (heterologous-control - lanes 10 and 12). Panel C: Lanes 1 and 2: amplicons from EHDV-7/AUS1981/06 using primer-pairs ‘7E1’ (700 bp)
and ‘7E2’ (730 bp). Lanes 5 and 8: products from EHDV-7/ISR2009/13 using primer-pairs ‘7W2’ (609 bp) and ‘7W1’ (1978 bp). Lanes 3, 4, 7 and 9:
primer-pairs ‘7E1’, ‘7E2’, ‘7W2’ and ‘7W1’generated no amplification products from EHDV-2/AUS1979/05 (heterologous-control). Panel D: Lanes 1 and
2: amplicons from EHDV-8/AUS1982/06 using primer-pairs ‘8E1’ (803 bp) and ‘8E2’ (772 bp). No amplification was detected from EHDV-6/BAR1983/01
(Lanes 3, 4) or EHDV-6/AUS1981/07 (lanes 5 and 6) (heterologous-controls). Lane M: 1 Kb marker. Lane +C: BTV-9/RSArrrr/09 using primer-pair BTV-9/
2/p377F & BTV-9/2/p485R (345 bp) (+ve control: Mertens et al [63]). Lane –C is a negative-control (water). For primer positions and sequences see
Table S1.
doi:10.1371/journal.pone.0012782.g002
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heterologous serotype to EHDV-7; Fig. 2 - Panel C). Our initial
attempts to design primers that would detect Seg-2 of any isolate of
EHDV-7 (regardless of topotype) were unsuccessful.
EHDV-8. Two primer-pairs (‘8E1’ and ‘8E2’) were designed
based on the sequence of an eastern strain of EHDV-8
(AUS1982/06 [Ac. No. AM745058]). Both pairs successfully
amplified cDNAs from Seg-2 of the homologous virus strain, but
no cross-reaction was observed with eastern or western strains of
EHDV-6 - the closest heterologous serotype to EHDV-8
(AUS1981/07 and BAR1983/01, respectively) (Fig. 2 - Panel D).
Typing of North African field isolates of EHDV from 2006
RNA was extracted from BHK-21 cells infected with Algerian
or Moroccan orbivirus isolates from 2006 (ALG2006/02 and
MOR2006/05, respectively). These viruses were distinct from
those used in the initial design of the EHDV ‘type-specific’ primers
described above. The RNAs were initially tested using an EHDV
‘group-specific’ RT-PCR assay, containing primers targeting Seg-
7 ([14], Table S1 - supporting information). In each case cDNA
bands of the expected size were generated (results not shown)
providing the initial identification of both isolates as EHDV. These
RNA preparations were also tested using a commercially available
EHDV ‘group-specific’ real-time RT-PCR (from LSI), giving cycle
threshold (CT) values of 12 and 14 respectively, confirming their
identity as EHDV.
ALG2006/02 and MOR2006/05 were subsequently tested by
RT-PCR, using ‘type-specific’ primers listed in Table S1
(supporting information). cDNAs of the predicted sizes (573 and
468 base pairs [bps] respectively) were generated from either RNA
preparation with primer-pairs ‘6W1’ and ‘6W2’. No cDNAs were
generated with any of the other primer-pairs, including those
directed against eastern strains of EHDV-6 (‘6E1’), providing the
first indication that both isolates belong to the western topotype of
EHDV-6 (EHDV-6[W]).
Full-length cDNA were also synthesised from Seg-2 of
ALG2006/02 and MOR2006/05, using an ‘anchor-primer’
ligated to the RNA 39 termini, then sequenced, as described by
Maan et al [70]. The Seg-2 sequences generated were identical,
reflecting the origin of both isolates from the same North African
outbreak in 2006. These full length Seg-2 sequences were
compared to EHDV strains belonging to each of the different
Figure 3. Neighbour-joining tree, showing relationships in Seg-2 between reference and field strains of EHDV. The tree was
constructed using distance matrices, generated using the p-distance determination algorithm in MEGA 4.1 (500 bootstrap replicates) [72]. EHD
viruses split into four distinct groups (A–D) based on Seg-2 sequences, reflecting serological relationships between virus strains [15]. Reference strains
of EHDV are shown in black and field isolates are shown in blue font. Isolate designations: IAH ‘dsRNA virus reference collection number composed of
‘country code, year, and the number of the isolate in that year from that country [48,49]. Full length Seg-2 sequences of Algerian and Moroccan 2006
strains were identical to each other and showed 97% nucleotide identity to the EHDV-6 [W]/BAR1983/01. ISR2006/13 showed 75% nucleotide identity
to the EHDV-7[E]/AUS1981/06 in the upstream terminal 2867 base pairs of Seg-2 sequence. Seg-2 (328–947 nt) of American 2006 isolates were
identical to each other and showed 97.7% identity to the EHDV-6 [E]/AUS1981/07. Seg-2 (120–684 nt) of Turkish 2007 isolates showed 98.9% identity
to each other and showed 96.2–96.8% identity to the EHDV-6 [W]/BAR1983/01 Scale represents number of substitutions per site. Values at major
branching points represent NJ bootstraps.
doi:10.1371/journal.pone.0012782.g003
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(nt) identity (97%) to BAR1983/01, the isolate of EHDV-6[W]
(previously identified as EHDV-318 – Fig. 3). This not only
confirms that both virus isolates belong to EHDV-6[W], but also
that primer-pairs ‘6W1’ and ‘6W2’ can be used to identify field
isolates of this serotype and topotype. Subsequent comparisons to
the reference strains of EHDV serotypes 1-8 [15] showed highest
levels of identity (72.6% nt and 77% aa) to Seg-2 of EHDV-6[E]
(AUS1981/07) and lowest levels (46% nt and 31% aa) to Seg-2 of
EHDV-2/CAN1962/01.
Virus neutralisation tests (VNTs) of ALG2006/02 and
MOR2006/05, showed high levels of neutralisation with reference
antisera against BAR1983/01 (EHDV-6[W]), reducing the titre of
either isolate by .5 log10 TCID50. No significant neutralisation
was detected using reference antisera against the other EHDV
serotypes, confirming both isolates as EHDV-6. Cross-neutralisa-
tion was previously detected in serum neutralisation tests (SNT)
between the reference strain of EHDV-6[E] (AUS1981/07) and
BAR1983/01, confirming that they both belong to the serotype 6
[15].
EHDV from Israel 2006
Ten orbivirus isolates were made in embryonated chicken eggs
(ECE) from the blood of cows showing clinical signs of disease in
Israel during 2006 (ISR2006/01 to ISR2006/09 and ISR2006/
13), then grown in BHK-21 cells. RNA extracted from the infected
cell pellet was tested using an EHDV group-specific RT-PCR
assay (targeting genome Seg-7 – [14], Table S1 - supporting
information), generating a cDNA band of the expected size
(1162 bp), and providing the first identification of these viruses as
EHDV (result not shown). ISR2006/13 was tested by VNT,
showing a reduction in titre of 2.5 Log10 TCID50 with reference
antisera to EHDV-7[E] (AUS1981/06), but no significant
reduction in titre with reference sera to the other EHDV
serotypes. A reduction of .2.0 Log10 is usually considered to be
indicative of the homologous serotype in this type of assay,
confirming the identity of ISR2006/13 as EHDV-7.
cDNA copies were subsequently synthesised from Seg-2 of
ISR2006/13, then sequenced using an ‘anchor spacer’ ligated to
39 termini of the RNA, as described by Maan et al [70]. The
upstream terminal 2867 nt/880 aa of Seg-2/VP2 were compared
to strains of different EHDV serotypes (Fig. 3), showing highest
levels of identity (75% nt/79% aa respectively) with the Australian
reference strain of EHDV-7 (AUS1981/06). The detection of
EHDV-7 sequences using anchor ligation indicates that EHDV-7
represented at least the dominant component of the virus
population in the sample tested.
Recent studies of BTV Seg-2 [73] have detected up to 31% nt
variation within a single serotype. Although the levels of nucleotide
sequence variation between and within individual EHDV
serotypes have not yet been fully explored, initial studies suggest
that the same may be true for EHDV [15]. The relationship
between Seg-2 of ISR2006/13 and that of other EHDV strains
(,30.5% nt identity), is therefore consistent with its serological
identification as EHDV-7 (with which it shares 75% nt identity).
However, the relationship is quite distant, suggesting that the
Australian and Israeli viruses (AUS1981/06 and ISR2006/13)
belong to different topotypes (E and W respectively). Seg-2 of
ISR2006/13 also showed slightly lower levels of identity with three
strains of EHDV-2 (69.3% nt/68.2% aa identity to AUS1979/05;
69.5% nt and 68% aa identity to JAP1959/01; and 67.8% nt/68%
aa identity to CAN1962/01). EHDV-2 is the most closely related
heterologous serotype to EHDV-7 (Group A - as described by
Anthony et al [15], Fig. 3).
The sequence of Seg-2 from ISR2006/13 was used to design
primers ‘7W1’ and ‘7W2’ (see assay development: above).
Although cDNAs of the correct size were amplified from Seg-2
of ISR2006/13 RNA using and ‘7W1’ and ‘7W2’, primers for
EHDV-6 (‘6W1’ and ‘6W2’) (Table S1 - supporting information)
also generated cDNA products of the expected size from this
sample (Fig. 2 – Panel C; Fig. 4 - Panel A and C), indicating that it
contained both EHDV types 6 and 7. The Seg-2 amplicons
generated from ISR2006/13 with primers ‘7W1’ and ‘7W2’
primers gave sequences identical to those obtained by anchor-
primer ligation (described above). However, the 573 and 468 bp
sequences generated from ISR2006/13 using primer-pairs ‘6W1’
and ‘6W2’s, showed 97% and 98.4% nt sequence similarity to
EHDV-6/BAR1983/01, confirming the presence of EHDV-6[W]
in the sample. These results also indicate that both EHDV-6[W]
and EHDV-7[W] were circulating in Israel during 2006 and
correlate with the subsequent detection of EHDV-6 [W] in Turkey
during 2007 (see below).
RT-PCR assays using RNA from other Israeli isolates from
2006 (ISR2006/01 to ISR2006/09), generated cDNAs of the
correct size with both pairs of EHDV-7 specific primers (‘7W1’
and ‘7W2’) but not with EHDV-6 specific primer-pairs as shown
in Fig. 4 – Panel B and D for ISR2006/09. Sequencing of Seg-2
amplicons from these isolates generated identical sequences (to
that of ISR2006/13) but showed only 73% nt sequence identity to
the reference strains of EHDV-7 (AUS1981/06) confirming the
presence of EHDV-7[W] in these Israeli samples.
An antiserum sample from Israeli cattle (from 2006), which
neutralised 100 TCID50 of the reference strain of EHDV-7[E]
(AUS1981/06) at a dilution of 1/320, gave a similar result in SNT
with EHDV-2 (the most closely related serotype to EHDV-7).
These serological typing results were therefore regarded as
inconclusive, but suggest that the animal could previously have
been infected with both EHDV-2 and EHDV-7. No results are
available for the reactivity of this serum sample with EHDV-6.
EHDV isolates from the USA 2006
The USA 2006 isolates were initially tested at the Southeastern
Cooperative Wildlife Disease Study (SCWDS), USA, for virus
neutralisation (VNT) using antisera to EHDV-1 and 2 [17], with
negative results. The virus isolates were then tested at USDA
National Veterinary Services Laboratories (NVSL) for virus
neutralisation using antisera to different EHDV serotypes. A
significant reduction in cytopathology was observed in wells
inoculated with these viruses and antiserum to EHDV-6 (CSIRO
753). No neutralisation was observed with antisera to EHDV
serotypes 1 (previously regarded as type 3), 4, 5, 7 and 8.
RNAs extracted from BHK-21 cells infected with five different
EHDV isolates from the USA 2006 (USA2006/05 and USA2006/
09), were tested with serotype-specific primers directed against
Seg-2 of different EHDV serotypes (Table S1 - supporting
information). Although strong bands of the expected sizes, were
detected with primer-pair ‘6A1’ (664 bp) and ‘6A2’ (859 bp), no
amplification was detected with primer-pairs for any of the other
EHDV serotypes or topotypes (including primer sets ‘6W1’ and
‘6W2’) (Fig. 5 - Panels A–E). The 664 bp PCR product was
sequenced from all five isolates (using ‘6A1’ sequencing primers)
and compared to Seg-2 of other EHDV strains (Fig. 3). The
highest nt identity level (97.7%) was detected with the Australian
reference strain of EHDV-6[E] (AUS1981/07), with lower levels
(72.5% identity) to Seg-2 of EHDV-6[W] (BAR1983/01),
identifying the serotype and topotype of the isolates as EHDV-
6[E]. The level of nt identity in Seg-2 between EHDV-6[E]
(AUS1981/07) and 6[W] (BAR1983/01) was 72.9%, while the
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ranged from 39.9%–66.6%.
EHDV isolates from Turkey 2007
RNAs extracted from six virus isolates derived from diagnostic
blood samples taken from cattle in Turkey during 2007
(TUR2007/01 to TUR2007/06, listed in Table 1) and a bovine
lung and spleen tissue homogenate sample (TUR2007/07 -
Table 1), were tested by conventional group-specific RT-PCR
assays (targeting Seg-7, [14], Table S1 - supporting information).
Although these samples were contaminated with bacteria and
appeared to be somewhat degraded, a positive result (with a cDNA
band of the expected size) was obtained. Real time diagnostic RT-
PCR assays for BTV [74], were negative for all of the samples,
although group-specific real time RT-PCR assay for EHDV (from
LSI) also gave a positive result, with CT values of 20.32–27.5. One
serum sample (number A162/07 13) from a different animal also
gave a weak +ve result for EHDV specific antibodies by ELISA
[75–77]. Subsequent RT-PCR assay, using primers ‘6W1’ and
‘6W2’ (Table S1 - supporting information), amplified cDNAs of
the appropriate sizes from isolates TUR2007/01, TUR2007/02,
TUR2007/03, TUR2007/04, and TUR2007/07, providing the
first identification of both the virus type and topotype (Fig. 6 -
Panels A–D). No amplification was detected with the other
serotype specific primers including ‘6E1’.
Sequencing and phylogenetic analyses of the cDNAs generated
(nt 120-684) from TUR2007/02 and TUR2007/07, showed
highest levels of nt sequence identity with BAR1983/01 (96.2–
96.6%) confirming the virus as EHDV-6[W]. Similarities of Seg-2
from TUR2007/02 and TUR2007/07 with other EHDV
serotypes ranged from 43.7% (EHDV-1/NIG1967/01 and
EHDV-7/AUS1981/06) to 72.2% (EHDV-8/AUS1982/06), with
EHDV-6[E] (AUS1981/07) showing 72.7% identity (Fig. 3). The
different isolates of EHDV-6 from Turkey from 2007 showed a
minimum level 98.9% nt sequence identity among themselves and
97.3% identity to Seg-2 (120–684 nt) of EHDV-6 ISR2006/13,
indicating that they all share a recent common ancestry and
suggest they represent continuation of a single outbreak.
Discussion
Serological ‘typing’ methods (VNT and SNT), based on the
specificity of interactions between neutralising antibodies and the
outer virion surface (particularly VP2), have been used for many
years and with considerable success, as primary diagnostic assays
to monitor outbreaks of orbiviral diseases and identify the
‘serotype’ of the virus involved. However, these assays are slow
and time consuming (taking weeks), and require access to stocks of
well characterised reference antisera and reference virus strains for
each serotype [78]. Serological assays are also unable to
distinguish individual strains within a single serotype, and are
therefore unsuitable for high precision epidemiological studies that
need to differentiate closely related virus lineages, or topotypes.
Seg-2 of both EHDV and BTV encodes VP2, the outermost
capsid protein and primary serotype-specific antigen of the virus
particle [13,79–81]. Seg-2/VP2 are also the most variable genome
segmentandprotein(.45.8%ntand.31.1%aaidentity),reflecting
the evolution of several distinct serotypes within each Orbivirus
species/serogroup, and the separation of strains from different
geographic origins, into distinct topotypes within these serotypes
[2,9,15,78,79,82–84]. This high degree of variability makes Seg-2/
VP2 ideal targets not only for the positive identification of each virus
Figure 4. Electrophoretic analysis of cDNA from Seg-2 of EHDV isolates from Israel 2006 using ‘type-specific’ primer-pairs. PCR
amplicons were generated from Seg-2 of ISR2006/13 - Panel A and ISR2006/09 - Panel B using primer-pairs ‘1E1’, ‘1W2’, ‘2A1’, ‘4W1’, ‘5E1’, ‘6E1’, ‘7E1’,
‘8E1’, 6W1’ (lanes 1 to 9). A 573 bp cDNA product was obtained with primer-pair ‘6W1’ in ISR2006/13 (lane 9 –Panel A, Table S1 - supporting
information) but not in ISR2006/09 (lane 9 – Panel B). Lane M: 1 Kb marker. +C is a positive control using RNA from EHDV-6/AUS1981/07, with primer-
pair ‘6A1’ – 664 bp. Lane -C is a negative water control showing no amplification. PCR amplicons were generated from Seg-2 of Israeli isolates
(ISR2006/13 –Panel C and ISR2006/09 – Panel D) using primer-pairs ‘1E1’, ‘1W2’, ‘2A1’, ‘4W1’, ‘5E1’, ‘6E1’, 6W1’, ‘7E1’, 7W2’ and ‘8E1’ (lanes 1 to 10
respectively). Expected size cDNA products of 573 and 609 bp were obtained with primer-pairs ‘6W1’ and ‘7W2’ in ISR2006/13 (lanes 7 and 9 – Panel
C, Table S1 - supporting information) but only one right sized product of 609 bp was obtained in ISR2006/09 with primer-pair ‘7W2’ (lane 9 – Panel
D). Lane M: 1 Kb marker. RNA from BTV-1/RSArrrr/01, with primer-pair ‘1A2’ – 1334 bp and BTV-9/RSArrrr/09, with primer-pair ‘9A2’ - 345 bp were
used as positive controls [63] (lane +C1 – Panel D and lane +C2 – Panel C, respectively). Lane -C is a negative water control showing no amplification.
doi:10.1371/journal.pone.0012782.g004
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amplicons were generated from Seg-2 of Turkish 2007 isolates, using primer-pairs ‘1E1’, ‘1W2’, ‘2A1’, ‘4W1’, ‘5E1’, ‘6E1’, ‘7E1’, ‘8E1’, and ‘6W1’ (lanes 1
to 9 respectively - Panels A–D). A cDNA product of 573 bp was obtained with primer-pair ‘6W1’ in all samples from Turkey (TUR2007/02, TUR2007/03,
TUR2007/04, and TUR2007/07) (lane 9 – Panels A–D, respectively, Table S1 - supporting information). Lane M: 1 Kb marker. Lane M2: 100 bp marker.
RNA from EHDV-6/AUS1981/07, with primer pair ‘6A1’ - 664 bp and EHDV-1/NIG1967/01 with primer-pair ‘1W2’ - 488 bp were used as positive
controls (lane +C in Panels A – C and Panel D, respectively). Lane -C is a negative water control showing no amplification.
doi:10.1371/journal.pone.0012782.g006
Figure 5. Electrophoretic analysis of cDNA from Seg-2 of EHDV isolates from USA using ‘type-specific’ primer-pairs. PCR amplicons
were generated from Seg-2 of isolates from USA, using primer-pairs ‘1E1’, ‘1W2’, ‘2A1’, ‘4W1’, ‘5E1’, ‘6A1’, ‘7E1’, ‘8E1’, ‘6W2’, ‘2A2’ and ‘6A2’ (lanes 1 to
11 respectively - Panels A–E). cDNA products of 664 and 859 bp were obtained with primer-pairs ‘6A1’ and ‘6A2’ in all isolates from USA (USA2006/05,
USA2006/06, USA2006/07, USA2006/08 and USA2006/09) (lanes 6 and 11 – Panels A–E, respectively, Table S1 - supporting information). Lane M: 1 Kb
marker. RNA from BTV-9/RSArrrr/09 was used as a positive control using primer-pair ‘9A2’ - 345 bp [63] (lane +C). Lane -C is a negative water control
showing no amplification.
doi:10.1371/journal.pone.0012782.g005
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between closely related virus strains [37,63].
Until recently the limited availability of reference ‘antisera and
isolates’ of individual EHDV serotypes and topotypes, have made
it difficult to determine the precise serological relationships that
exist between different orbivirus strains, by conventional serolog-
ical methodologies (VNT and SNT assays). Consequently there is
some uncertainty in the literature concerning the total number of
EHDV serotypes [2,64,85–87]. Between 8-10 serotypes/strains of
EHDV (serotypes 1–8, EHDV-318 and Ibaraki virus (IBAV) have
been suggested in the literature [2], although the most recent study
by Anthony et al [15] has grouped type 1 and 3 together (as
EHDV-1) and strain 318 as a western strain of type 6, making a
total of only seven distinct EHDV serotypes.
In contrast 25 serotypes of BTV have been identified by
serological assays as well as phylogenetic comparisons of Seg-2/
VP2 [63,73,88–90]. Recently a sequence database for Seg-2 of
BTV [73], was used to design oligonucleotide primers and probes
for conventional and real-time RT-PCR assays to identify
individual BTV types (conventional assays - Mertens et al [63];
in preparation; real-time assays available from LSI).
Anthony et al [15,91,92] compared full-genome sequence data
for ‘reference’ strains of EHDV, confirming that (like BTV)
variations in Seg-2/VP2 correlate with virus serotype. These data
have supported the design of EHDV ‘serotype-specific’ primers for
use in the RT-PCR assays described here. Multiple primer sets
targeting Seg-2 of each EHDV serotype were evaluated, in
particular for their ability to identify and discriminate between
reference strains or available field isolates of different EHDV
serotypes and topotypes, as well as other related orbiviruses,
confirming their specificity.
These Seg-2 specific RT-PCR assays and primers, together with
associated sequencing studies, allow individual EHDV serotypes
(and topotype) to be identified with greater accuracy, sensitivity
and more rapidly than by conventional serological typing
methods. It is now also possible to identify individual strains and
lineages within a single EHDV serotype in a manner that is
impossible by conventional serological typing methods, facilitating
intense surveillance. These assays can also provide Seg-2
amplicons for sequencing – allowing comparisons to identify
serotype, topotype and strain with great precision. Although
primer sets were identified that were specific for Seg-2 of each
serotype, these vary in their ability to prime cDNA synthesis from
different isolates. This reflects high levels of sequence variability in
Seg-2 of BTV and related orbiviruses, even within a single
serotype, depending largely on the geographical origin (topotype)
of the isolate [15,36].
In recent years (2006–2007), several EHD outbreaks caused by
different serotypes that have occurred in different locations around
the world, have been identified using the type-specific assays
described here. These include EHDV-6[W] recently recognized as
an emerging pathogen of cattle in Algeria, Morocco (in 2006) and
Turkey (2007) [34]. EHDV-7[W] was also identified in Israel in
2006 [35]. EHDV isolates from white-tailed deer in Indiana and
Illinois [17], were confirmed as type 6 and for the first time
identified as an eastern topotype of type 6 (EHDV-6[E]), a
serotype and topotype originally isolated in Australia. Genetic
characterization of EHDV-6[E] Indiana (304-06) [17] showed that
it is a reassortant virus, with outer capsid proteins that determine
serotype (VP2 and VP5) derived from an exotic strain of EHDV-
6[E], although how this strain arrived in the USA remains
uncertain. The remaining structural and non-structural proteins
are derived from an indigenous strain of EHDV-2 (Alberta),
making it difficult to distinguish this strain from other American
strains of EHDV using group specific serological or RNA sequence
based assays (RT-PCR) that target these more conserved genome
segments and proteins.
These studies highlight a need to establish reference strains for
both eastern and western topotypes of each EHDV serotype, with
associated sequence data for Seg-2 (as listed in Table 1; [48]). The
new EHDV ‘type-specific’ assay systems described here provide a
valuable tool for future studies, to provide more information
concerning the persistence and movements of individual virus
strains in the field. The assays were designed based on sequence
data from a limited pool of available EHDV strains, primarily to
distinguish between isolates of the different EHDV serotypes, and
the resulting assays are successful in this respect. However, it is
possible that EHDV strains will be identified in the future that
cross-react by RT-PCR assay with heterologous serotypes, or fail
to amplify using these type-specific primers. This will require
further sequence analyses/comparison and primer redesign to
maintain the efficacy and specificity of these assays. The fine-scale
differentiation between individual EHDV strains within each
serotype and topotype depends on the availability and character-
isation of well documented isolates, such as those stored and
maintained in the reference collection at IAH Pirbright [48,49].
Conventional and real-time RT-PCR assays will inevitably
increase the speed and reliability of laboratory-based diagnostic
testing for EHDV. It is not easy to compare the sensitivity and
specificity of type-specific and group-specific, conventional and
real-time RT-PCR assays, targeting different orbivirus genome
segments, in a meaningful way. However, in our experience of
routine detection of BTV and EHDV RNA in diagnostic tissue
samples, or cell-culture materials [14,64–68,74], those samples
that give CT values of ,30 by real-time PCR (equivalent to ,100
copies – data supplied by LSI for their Seg-9 based EHDV group-
specific assay), will also reliably generate cDNA amplicons by
conventional RT-PCR assay targeting the appropriate Seg-2 [63].
The serotype specific assays described here can be used to detect
and ‘type’ individual strains of EHDV in the absence of reference
antisera for each serotype. Unlike real-time RT-PCR assays, the
conventional type-specific primers can also be used to sequence
any of the cDNA amplicons that are generated, providing further
and definitive proof of the relationships between individual virus
strains in Seg-2. Phylogenetic comparisons of the resulting EHDV
Seg-2 sequences will help determine the worldwide prevalence and
distribution of different EHDV serotypes and topotypes, improv-
ing our understanding of the epidemiology and transmission of the
virus. The data generated will inform the design and implemen-
tation of future control strategies, including vaccination.
Supporting Information
Table S1 Primers for specific amplification of Seg-2 from
various EHDV serotypes in RT-PCR assays.
Found at: doi:10.1371/journal.pone.0012782.s001 (0.11 MB
DOC)
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